Article Details

Vanguard Group Inc. Acquires New Position in Y-mAbs Therapeutics, Inc (YMAB)

Retrieved on: 2019-03-29 10:48:45

Tags for this article:

Click the tags to see associated articles and topics

Vanguard Group Inc. Acquires New Position in Y-mAbs Therapeutics, Inc (YMAB). View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new position in Y-mAbs Therapeutics in the 3rd quarter valued at about $55,890,000. Scopia Capital Management ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up